New York State Common Retirement Fund’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.74K Hold
9,100
﹤0.01% 3155
2026
Q1
$34.1K Hold
9,100
﹤0.01% 2916
2025
Q4
$32.1K Hold
9,100
﹤0.01% 3015
2025
Q3
$36.4K Hold
9,100
﹤0.01% 3017
2025
Q2
$24.4K Hold
9,100
﹤0.01% 3092
2025
Q1
$12.8K Hold
9,100
﹤0.01% 3046
2024
Q4
$18.1K Hold
9,100
﹤0.01% 3056
2024
Q3
$28.7K Sell
9,100
-26,500
-74% -$83.6K ﹤0.01% 2994
2024
Q2
$112K Buy
+35,600
New +$141K ﹤0.01% 2690

Other funds holding ADCT

New York State Common Retirement Fund's ADCT Position: Q2 2026 in Review

New York State Common Retirement Fund held its ADC Therapeutics (ADCT) position steady in Q2 2026 at 9,100 shares worth $9.74K. The position accounts for ﹤0.01% of the portfolio, ranked #3155.

New York State Common Retirement Fund first reported a position in ADCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $112K in Q2 2024. 18 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

  • New York State Common Retirement Fund held 9,100 shares of ADC Therapeutics worth $9.74K as of Q2 2026.
  • New York State Common Retirement Fund left its ADC Therapeutics share count unchanged in Q2 2026.
  • ADC Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3155 holding.
  • New York State Common Retirement Fund first reported a position in ADC Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • New York State Common Retirement Fund's ADC Therapeutics position peaked at $112K in Q2 2024.
  • 18 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.